MedTrace Logo

Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

NCT05001646 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-03-14

No results posted yet for this study

Summary

This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.

Conditions

  • Aging
  • Aging Well

Interventions

DEVICE

In-home resonance-based electromagnetic field protection device

Participants will have an in-home EMF protection device

Sponsors & Collaborators

  • Blushield USA

    collaborator UNKNOWN

  • TruDiagnostic

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-01-31
Completion
2023-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05001646 on ClinicalTrials.gov